|4Feb 9, 6:25 PM ET

Lien Lyndon 4

4 · Kindred Biosciences, Inc. · Filed Feb 9, 2021

Insider Transaction Report

Form 4
Period: 2021-02-05
Lien Lyndon
Director
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-05+47,00047,000 total
    Exercise: $5.08Exp: 2031-02-04Common Stock (47,000 underlying)
Footnotes (1)
  • [F1]The option will vest in four equal quarterly installments from the option grant date.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT